Risk factors for febrile status epilepticus: a case-control study.


Journal Article

OBJECTIVE: To identify risk factors for developing a first febrile status epilepticus (FSE) among children with a first febrile seizure (FS). STUDY DESIGN: Cases were children with a first FS that was FSE drawn from the Consequences of Prolonged Febrile Seizures in Childhood and Columbia cohorts. Controls were children with a first simple FS and separately, children with a first complex FS that was not FSE. Identical questionnaires were administered to family members of the 3 cohorts. Magnetic resonance imaging protocol and readings were consistent across cohorts, and seizure phenomenology was assessed by the same physicians. Risk factors were analyzed using logistic regression. RESULTS: Compared with children with simple FS, FSE was associated with younger age, lower temperature, longer duration (1-24 hours) of recognized temperature before FS, female sex, structural temporal lobe abnormalities, and first-degree family history of FS. Compared with children with other complex FS, FSE was associated with low temperature and longer duration (1-24 hours) of temperature recognition before FS. Risk factors for complex FS that was not FSE were similar in magnitude to those for FSE but only younger age was significant. CONCLUSIONS: Among children with a first FS, FSE appears to be due to a combination of lower seizure threshold (younger age and lower temperatures) and impaired regulation of seizure duration. Clinicians evaluating FS should be aware of these factors as many episodes of FSE go unnoticed. Further work is needed to develop strategies to prevent FSE.

Full Text

Duke Authors

Cited Authors

  • Hesdorffer, DC; Shinnar, S; Lewis, DV; Nordli, DR; Pellock, JM; Moshé, SL; Shinnar, RC; Litherland, C; Bagiella, E; Frank, LM; Bello, JA; Chan, S; Masur, D; Macfall, J; Sun, S; Consequences of Prolonged Febrile Seizures in Childhood (FEBSTAT) Study Team,

Published Date

  • October 2013

Published In

Volume / Issue

  • 163 / 4

Start / End Page

  • 1147 - 51.e1

PubMed ID

  • 23809042

Pubmed Central ID

  • 23809042

Electronic International Standard Serial Number (EISSN)

  • 1097-6833

Digital Object Identifier (DOI)

  • 10.1016/j.jpeds.2013.05.038


  • eng

Conference Location

  • United States